1021 related articles for article (PubMed ID: 25593281)
21. Hematopoietic Stabilin-1 deficiency does not influence atherosclerosis susceptibility in LDL receptor knockout mice.
Nahon JE; Hoekstra M; van Hulst S; Manta C; Goerdt S; Geerling JJ; Géraud C; Van Eck M
Atherosclerosis; 2019 Feb; 281():47-55. PubMed ID: 30658191
[TBL] [Abstract][Full Text] [Related]
22. Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.
Adamson SE; Polanowska-Grabowska R; Marqueen K; Griffiths R; Angdisen J; Breevoort SR; Schulman IG; Leitinger N
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1020-1029. PubMed ID: 29599136
[TBL] [Abstract][Full Text] [Related]
23. Fluid-phase pinocytosis of native low density lipoprotein promotes murine M-CSF differentiated macrophage foam cell formation.
Barthwal MK; Anzinger JJ; Xu Q; Bohnacker T; Wymann MP; Kruth HS
PLoS One; 2013; 8(3):e58054. PubMed ID: 23536783
[TBL] [Abstract][Full Text] [Related]
24. Macrophage foam-cell formation in streptozotocin-induced diabetic mice: stimulatory effect of glucose.
Hayek T; Hussein K; Aviram M; Coleman R; Keidar S; Pavoltzky E; Kaplan M
Atherosclerosis; 2005 Nov; 183(1):25-33. PubMed ID: 16216589
[TBL] [Abstract][Full Text] [Related]
25. Hematopoietic arginase 1 deficiency results in decreased leukocytosis and increased foam cell formation but does not affect atherosclerosis.
Ren B; Van Kampen E; Van Berkel TJ; Cruickshank SM; Van Eck M
Atherosclerosis; 2017 Jan; 256():35-46. PubMed ID: 27998825
[TBL] [Abstract][Full Text] [Related]
26. Macrophage Lxrα reduces atherosclerosis in Ldlr
Yin Y; Zeng S; Li Y; Wu Z; Huang D; Gao P
Biochem Biophys Res Commun; 2020 Aug; 529(3):540-547. PubMed ID: 32736671
[TBL] [Abstract][Full Text] [Related]
27. Bone marrow-derived multidrug resistance protein ABCB4 protects against atherosclerotic lesion development in LDL receptor knockout mice.
Pennings M; Hildebrand RB; Ye D; Kunne C; Van Berkel TJ; Groen AK; Van Eck M
Cardiovasc Res; 2007 Oct; 76(1):175-83. PubMed ID: 17560559
[TBL] [Abstract][Full Text] [Related]
28. Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis.
Bi X; Zhu X; Duong M; Boudyguina EY; Wilson MD; Gebre AK; Parks JS
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2288-96. PubMed ID: 23814116
[TBL] [Abstract][Full Text] [Related]
29. Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.
Nagashima M; Watanabe T; Shiraishi Y; Morita R; Terasaki M; Arita S; Hongo S; Sato K; Shichiri M; Miyazaki A; Hirano T
Atherosclerosis; 2010 Sep; 212(1):70-7. PubMed ID: 20684826
[TBL] [Abstract][Full Text] [Related]
30. Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice.
van der Sluis RJ; Nahon JE; Reuwer AQ; Van Eck M; Hoekstra M
Br J Pharmacol; 2015 May; 172(9):2397-405. PubMed ID: 25572138
[TBL] [Abstract][Full Text] [Related]
31. IL-33 reduces macrophage foam cell formation.
McLaren JE; Michael DR; Salter RC; Ashlin TG; Calder CJ; Miller AM; Liew FY; Ramji DP
J Immunol; 2010 Jul; 185(2):1222-9. PubMed ID: 20543107
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional control of intestinal cholesterol absorption, adipose energy expenditure and lipid handling by Sortilin.
Hagita S; Rogers MA; Pham T; Wen JR; Mlynarchik AK; Aikawa M; Aikawa E
Sci Rep; 2018 Jun; 8(1):9006. PubMed ID: 29899496
[TBL] [Abstract][Full Text] [Related]
33. Absence of hyperlipidemia in LDL receptor-deficient mice having apolipoprotein B100 without the putative receptor-binding sequences.
Johnson LA; Altenburg MK; Walzem RL; Scanga LT; Maeda N
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1745-52. PubMed ID: 18617647
[TBL] [Abstract][Full Text] [Related]
34. Rho-associated coiled-coil-containing kinase 2 deficiency in bone marrow-derived cells leads to increased cholesterol efflux and decreased atherosclerosis.
Zhou Q; Mei Y; Shoji T; Han X; Kaminski K; Oh GT; Ongusaha PP; Zhang K; Schmitt H; Moser M; Bode C; Liao JK
Circulation; 2012 Oct; 126(18):2236-47. PubMed ID: 23011471
[TBL] [Abstract][Full Text] [Related]
35. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.
Jiang H; Zhang J; Du Y; Jia X; Yang F; Si S; Wang L; Hong B
Atherosclerosis; 2015 Dec; 243(2):523-32. PubMed ID: 26523989
[TBL] [Abstract][Full Text] [Related]
36. Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA.
Dai XY; Cai Y; Sun W; Ding Y; Wang W; Kong W; Tang C; Zhu Y; Xu MJ; Wang X
Cardiovasc Res; 2014 Feb; 101(2):297-305. PubMed ID: 24253523
[TBL] [Abstract][Full Text] [Related]
37. Cysteamine inhibits lysosomal oxidation of low density lipoprotein in human macrophages and reduces atherosclerosis in mice.
Wen Y; Ahmad F; Mohri Z; Weinberg PD; Leake DS
Atherosclerosis; 2019 Dec; 291():9-18. PubMed ID: 31629988
[TBL] [Abstract][Full Text] [Related]
38. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
[TBL] [Abstract][Full Text] [Related]
39. Preventive effects of heregulin-beta1 on macrophage foam cell formation and atherosclerosis.
Xu G; Watanabe T; Iso Y; Koba S; Sakai T; Nagashima M; Arita S; Hongo S; Ota H; Kobayashi Y; Miyazaki A; Hirano T
Circ Res; 2009 Aug; 105(5):500-10. PubMed ID: 19644050
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.
Meiler S; Baumer Y; Toulmin E; Seng K; Boisvert WA
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):323-31. PubMed ID: 25524771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]